Tilray Inc. (TLRY) experienced a significant 24.56% surge in pre-market trading, driven by two key developments. First, the company announced the launch of its new Amped Live Resin Liquid Diamond 1g 510 cartridges under the Redecan cannabis brand. This marks Redecan's first entry into the live resin-liquid diamond vape category, a segment that has seen growing consumer demand in Canada.
Second, speculation about the U.S. government reclassifying marijuana as a less dangerous drug has fueled investor optimism. Reports suggest President Donald Trump is considering moving cannabis from Schedule I to Schedule III, which would ease regulatory burdens and open up new opportunities for cannabis companies like Tilray.
These developments have combined to create strong bullish sentiment around Tilray's stock, leading to the pre-market rally.
Comments